Nathan Rice's Stock Ratings

Piper Sandler Analyst

Nathan Rice is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2024

Overall Average Return

12.7%

Smart Score

65.3%

Overall Average Return Percentile

66th

Number of Ratings

27
Buy NowGet Alert
05/03/2024MBINBuy Now
Merchants Bancorp
$43.0435.92%$53 → $58.5ReiteratesOverweight → OverweightGet Alert
05/02/2024CVSBuy Now
CVS Health
$56.3031.44%$85 → $74MaintainsBuyGet Alert
04/29/2024FMBHBuy Now
First Mid Bancshares
$33.2114.42%$39 → $38MaintainsOverweightGet Alert
04/18/2024BFCBuy Now
Bank First
$83.883.72%$90 → $87MaintainsNeutralGet Alert
02/02/2024ALGNBuy Now
Align Tech
$280.32-19.73%$197 → $225MaintainsSellGet Alert
01/30/2024BYBuy Now
Byline Bancorp
$23.5818.74%$27 → $28MaintainsOverweightGet Alert
01/18/2024BFCBuy Now
Bank First
$83.8810.87%$88 → $93MaintainsNeutralGet Alert
01/10/2024NICBuy Now
Nicolet Bankshares
$82.172.23% → $84Assumes → NeutralGet Alert
01/09/2024BFCBuy Now
Bank First
$83.884.91% → $88Assumes → NeutralGet Alert
12/11/2023ALGNBuy Now
Align Tech
$280.32-29.72% → $197DowngradeNeutral → SellGet Alert
08/16/2023FMBHBuy Now
First Mid Bancshares
$33.218.4%$33 → $36MaintainsOverweightGet Alert
07/31/2023MBINBuy Now
Merchants Bancorp
$43.04-11.71%$31 → $38MaintainsOverweightGet Alert
07/27/2023ALGNBuy Now
Align Tech
$280.3240.2%$343 → $393MaintainsNeutralGet Alert
05/05/2023CVSBuy Now
CVS Health
$56.3056.31%$100 → $88MaintainsBuyGet Alert
05/01/2023MBINBuy Now
Merchants Bancorp
$43.04-27.97%$35 → $31MaintainsOverweightGet Alert
04/25/2023ELANBuy Now
Elanco Animal Health
$17.04-47.18%$10.5 → $9MaintainsSellGet Alert
02/02/2023ALGNBuy Now
Align Tech
$280.329.52% → $307UpgradeSell → NeutralGet Alert
12/13/2022BHGBuy Now
Bright Health Gr
—— → $40DowngradeNeutral → SellGet Alert
10/27/2022ALGNBuy Now
Align Tech
$280.32-41.14%$250 → $165MaintainsSellGet Alert
07/28/2022ALGNBuy Now
Align Tech
$280.32-10.82%$380 → $250DowngradeBuy → SellGet Alert
07/21/2022IDXXBuy Now
IDEXX Laboratories
$548.53-20.7%$530 → $435UpgradeNeutral → BuyGet Alert
05/19/2022IDXXBuy Now
IDEXX Laboratories
$548.53-3.38%$615 → $530MaintainsNeutralGet Alert
12/14/2021CIBuy Now
Cigna
$344.41-32.35%—Initiates → NeutralGet Alert
12/14/2021CNCBuy Now
Centene
$78.096.29%—Initiates → NeutralGet Alert
02/01/2021ALGNBuy Now
Align Tech
$280.32122.96%$561 → $625MaintainsBuyGet Alert
10/23/2020ALGNBuy Now
Align Tech
$280.3268.38%$355 → $472MaintainsBuyGet Alert
07/23/2020ALGNBuy Now
Align Tech
$280.3219.51%$294 → $335MaintainsBuyGet Alert

Recent Analyst Stock Rating News

7 Analysts Assess Align Tech: What You Need To Know
Forecasting The Future: 5 Analyst Projections For Align Tech
Expert Outlook: Align Tech Through The Eyes Of 5 Analysts
What Analysts Are Saying About Align Tech Stock
Here's Why Align Technology Stock Is Soaring
Align Technology Inc (NASDAQ: ALGN) shares are ripping higher Thursday after the company reported better-than-expected financial results and announced a buyback. Multiple analysts are out with positive coverage following the print.
Dan Nathan's Consumer Staples Select Sect. SPDR (ETF) Trade
The 100 Highest-Paid University Presidents
Beacon Roofing Supply to Acquire Roofing Supply Group from Clayton, Dubilier & Rice for $1.1B in Cash and Stock
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free